Contributors
Rick R. Adler(GlaxoSmithKline (United States)), Lois D. Lehman‐McKeeman(Bristol-Myers Squibb (Sweden)), Danielle L. Brown(Charles River Laboratories (United States)), Dino Bradley(Janssen (United States)), Thomas Forest, Bindu Bennet(Fate Therapeutics (United States)), Laura E. Armstrong(Rutgers, The State University of New Jersey), Brad Bolon(NewPath Research), Wanda M. Haschek(University of Illinois Urbana-Champaign), Armando R. Irizarry Rovira(Eli Lilly (United States)), Jennifer L. Ingram–Ross, Isabel Figueroa(Merck & Co., Inc., Rahway, NJ, USA (United States)), Kristi L. Helke, Angela King-Herbert, Adam D. Aulbach(MPI Research (United States)), Catherine A. Foss, James Fikes, Evan B. Janovitz(Bristol-Myers Squibb (Germany)), Jerry F. Hardisty, Pierre R. Bushel(Research Triangle Park Foundation), Molly Boyle(Covance (United States)), Frank J. Geoly(North Carolina State University), Jennifer A. Chilton, Shayne C. Gad(Unknown), John R. Foster, Jeffrey I. Everitt(Duke University), Dmitri Artemov(Johns Hopkins University), Christopher Bowman(University of California, San Francisco), Lauren E. Himmel(The Ohio State University), Kathleen L. Gabrielson(Johns Hopkins University), Steven T. Laing, Charlotte M. Keenan, Peter Clements(GlaxoSmithKline (United Kingdom)), Ellen A. Cannady(Eli Lilly (United States)), Mark F. Cesta(North Carolina State University), Eric A.G. Blomme(AbbVie (United States)), Kapil Gadkar(Sea Turtle Conservancy), Famke Aeffner(University of Veterinary Medicine Hannover, Foundation), Torrie A. Crabbs(Experimental Pathology Laboratories), Jinping Gan(Bristol-Myers Squibb (United States)), Mark J. Hoenerhoff(University of Michigan), Alys Bradley(Charles River Laboratories (United Kingdom)), David Garcia-Tapia, Daniela Ennulat(GlaxoSmithKline (United States)), Curtis M. Chan(Charles River Laboratories (United States)), Kathleen M. Heinz-Taheny, Kishore Katyayan, Wendy Halpern(Roche (Switzerland)), Myrtle A. Davis(National Institutes of Health), Sandy Eldridge
Cited by 0
Related Papers
The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance
|Nature Biotechnology|2014|550
Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease
|Nature Genetics|2001|512
Inhaled carbon nanotubes reach the subpleural tissue in mice
|Nature Nanotechnology|2009|465
Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium
|Nature Biotechnology|2010|406
Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project
|Toxicology and Applied Pharmacology|2003|386